Increased frequency of co-existing<i>JAK2</i>exon-12 or<i>MPL</i>exon-10 mutations in patients with low<i>JAK2<sup>V617F</sup></i>allelic burden

Roberto Nussenzveig(University Pathologists), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Hà Phạm(Bellbrook Labs (United States)), Josef T. Prchal(Huntsman Cancer Institute), Archana M. Agarwal(University of Utah), Sherrie L. Perkins(University of Utah)
Leukemia & lymphoma/Leukemia and lymphoma
September 30, 2015
Cited by 18


Related Papers